SCC Scares, Lichen Planus Cancer Risks, CSU Breakthroughs, Psoriasis Wins, Chemo Hacks, and HS Itch Relief

Buckle up for a whirlwind tour of the hottest dermatology literature. This week, we’ve got the deets on:Cutaneous squamous cell carcinoma: What predicts when it'll go rogue and metastasize? Spoiler: It’s not just bad vibes.Oral lichen planus: Turns out, its cancer risk is sneakier than a derm resident dodging clinic.Remibrutinib for CSU: The first oral game-changer for chronic spontaneous urticaria. Hives, meet your match!Psoriasis biologics: Which systemic treatments keep infections at bay? We’ve got the lowdown.Chemo’s conundrum: One bizarre trick to stop a cutaneous side effectsHidradenitis suppurativa itch: Dermeleve’s here to make HS patients stop scratching and start living.Join us for laughs, learning, and maybe a few gasps as we unpack the science that’s got the derm world buzzing. Perfect for dermatologists, PAs, NPs, pharma folks, and students who live for skin-deep insights. Subscribe, share, and let’s make dermatology lit!  #DermatologyPodcast #DermLifeScholarsinMedicine.com⁠

Om Podcasten

Derms on Drugs is where cutting-edge dermatology meets mediocre comedy. Each week three dermatologists – Matt Zirwas, Laura Ferris and Tim Patton – discuss, debate, and dissect the hottest topics in dermatology. It's everything you need to know to be on the cutting-edge of dermatology and it’ll be the most fun you’ve ever had while actually learning something useful. Derms on Drugs is produced by Scholars in Medicine, an online educational platform (scholarsinmedicine.com) exclusively for healthcare professionals of all levels of experience and education.